Shock Rosen
Shock Rosen
Shock Rosen
Shock
Michael A. Puskarich | Alan E. Jones
BOX 6.1
The second phase of organ injury from hemorrhagic shock sepsis in hospitalized patients, indicating that the pathophysiology
occurs during resuscitation. The acute phase of hemorrhage initi- of sepsis cannot be explained simply by the response to LPS.
ates the inflammatory cascade, and resuscitation unleashes these Septic shock often causes three major effects that must be
volatile inflammatory mediators on the body, inducing organ addressed during resuscitation—hypovolemia, cardiovascular
injury. During resuscitation, neutrophils become more aggressive, depression, and induction of systemic inflammation. Septic shock
binding to the lung endothelium and causing capillary leakage produces relative and absolute hypovolemia, reducing right ven-
that characterizes acute respiratory distress syndrome (ARDS). tricular filling. Absolute hypovolemia results from gastrointestinal
Inflammatory cytokines are liberated, causing additional cellular volume loss, tachypnea, sweating, and decreased fluid intake
damage and compounded by persistent microischemia in numer- during development of the illness. Further relative hypovolemia
ous organs due to an imbalance between vasodilation by nitric results from increasing venous capacitance in conjunction with
oxide (NO) and vasoconstriction by endothelins. The liver dem- increased capillary leak and resultant loss of intravascular volume
onstrates centrilobular injury, demonstrated clinically by elevated into third spaces. Septic shock causes direct myocardial depres-
transaminase levels, whereas the kidney may manifest acute spasm sion. Measurements of cardiac contractility have shown that
of the preglomerular arterioles, with resultant acute tubular mechanical function becomes impaired early in the course of
necrosis. A growing body of evidence has suggested that resuscita- septic shock, even in the hyperdynamic stages. Circulating media-
tion from hemorrhage exerts greater injury on the heart than the tors, myocardial cellular injury from inflammation, and deranged
actual hypotensive insult. metabolism interact synergistically to injure the heart during
septic shock, and specific cytokines (most notably tumor necrosis
Septic Shock factor alpha [TNF-α] and interleukin-1 beta [IL-1β]), overpro-
duction of NO by inducible nitric oxide synthase (iNOS), and
Although historically presented as the archetype of vasogenic or possibly impairment in mitochondrial oxidative phosphorylation,
distributive shock, in reality the clinical course of septic shock is may all play a role. Similar to hemorrhagic shock, systemic inflam-
much more complex and varies over the course of the disease, mation causes capillary leak in the lung, resulting in ARDS. Wide-
with variables degrees of intravascular volume depletion, periph- spread systemic inflammation likely plays a role in the development
eral vasodialation, and impaired cardiac function. Septic shock and persistence of multisystem organ failure in sepsis through
can be produced by infection with any microbe, although in half microvascular and mitochondrial dysfunction. Clinical trials to
or more of cases of septic shock, no organism is identified. One date have yet to demonstrate the effectiveness of specific or general
well-known mediator of sepsis is lipopolysaccharide (LPS), con- antiinflammatory therapies in mitigating this response, and the
tained in the outer cell membrane of gram-negative bacteria; treatment of septic shock relies primarily on the reversal of shock,
however, gram-positive organisms are now the primary cause of supportive care, and source control.
Descargado para Juan Carlos Hoyos Figueroa ([email protected]) en Universidad Ces de ClinicalKey.es por Elsevier en julio 13, 2018.
Para uso personal exclusivamente. No se permiten otros usos sin autorización. Copyright ©2018. Elsevier Inc. Todos los derechos reservados.
70 PART I Fundamental Clinical Concepts | SECTION One Critical Management Principles
Descargado para Juan Carlos Hoyos Figueroa ([email protected]) en Universidad Ces de ClinicalKey.es por Elsevier en julio 13, 2018.
Para uso personal exclusivamente. No se permiten otros usos sin autorización. Copyright ©2018. Elsevier Inc. Todos los derechos reservados.
CHAPTER 6 Shock 71
Fig. 6.1. Flow diagram to classify undifferentiated shock. 2. Septic shock. International consensus definitions distinguish
septic shock from its precursor conditions—systemic inflam-
matory response syndrome (SIRS), sepsis, and severe sepsis.9
SIRS is often a precursor of shock, but the nonspecific criteria
emergency clinician’s ability to accurately diagnose the cause of for SIRS are found in a large variety of conditions, many of
undifferentiated shock in ED patients, and the finding of hyper- which are benign, so the clinical context is vital to understand-
dynamic left ventricular function in patients with undifferentiated ing the significance of these physiologic variations. Although
shock strongly suggests sepsis.6,7 a consensus definition of septic shock requires persistent hypo-
Consensus definitions of shock show the spectrum of tension after fluid resuscitation, initiation of treatment for
hypoperfusion for the following three common causes of shock empirically diagnosed severe sepsis or septic shock should not
(Box 6.3): await the onset of hypotension. The incorporation of an indi-
1. Hemorrhagic shock. The American College of Surgeons has cator of tissue hypoperfusion (Box 6.4) into the clinical assess-
divided hemorrhagic shock into four stages, depending on the ment may improve identification of hypoperfusion, particularly
severity of blood loss and physiologic response to this loss, but in subtle cases.10
such arbitrary divisions are of little value and are not accurate 3. Cardiogenic shock. Cardiogenic shock should be thought to be
reflections of degree of hemorrhage in clinical practice.8 A present whenever cardiac failure (ischemic, toxic, or obstruc-
more useful approach defines hemorrhagic shock as being tive) causes systemic hypoperfusion that manifests as lactic
present when systemic hypoperfusion manifests as lactic acidosis with organ dysfunction.
acidosis or increasing base deficit with concomitant organ Box 6.5 presents the general treatment approach for these three
dysfunction. common causes of shock.
Descargado para Juan Carlos Hoyos Figueroa ([email protected]) en Universidad Ces de ClinicalKey.es por Elsevier en julio 13, 2018.
Para uso personal exclusivamente. No se permiten otros usos sin autorización. Copyright ©2018. Elsevier Inc. Todos los derechos reservados.
72 PART I Fundamental Clinical Concepts | SECTION One Critical Management Principles
Descargado para Juan Carlos Hoyos Figueroa ([email protected]) en Universidad Ces de ClinicalKey.es por Elsevier en julio 13, 2018.
Para uso personal exclusivamente. No se permiten otros usos sin autorización. Copyright ©2018. Elsevier Inc. Todos los derechos reservados.
CHAPTER 6 Shock 73
preferable method for pulmonary artery catheter placement in departmental, or individual preferences. Initial volume replace-
the ED. ment consists of the rapid infusion of 20 to 25 mL of isotonic
Quantitative resuscitation, which incorporates multiple indices crystalloid per kilogram.
of circulatory and oxygenation status, has been shown in meta-
analyses to reduce mortality and morbidity in ED patients with Colloids and Hypertonic Saline. Colloids, including
severe sepsis or septic shock significantly when instituted as early albumin, have been used in patients with hemorrhage, but at
in the disease course as is practical. In such an approach, patients considerable increase in cost and without effect on morbidity
are resuscitated early, within the first 6 hours, to achieve normal- or mortality. Colloids offer the theoretic advantage of a high
ization of markers of volume status, perfusion, and adequate osmotic pressure, which should help maintain normal intravas-
oxygen delivery (Fig. 6-2). The first description of an ED-based cular volume. Initial resuscitation fluid treatment with hyper-
quantitative resuscitation strategy targeted specific volume, perfu- tonic saline or hypertonic saline and dextran, compared with
sion, and oxygen delivery endpoints and was termed early goal- normal saline, has not been found to result in superior 28-day
directed therapy (EGDT).14 Recently, three large multicenter trials survival.18
did not demonstrate a mortality advantage for patients receiving In the setting of septic shock, initial fluid resuscitation should
the complex and invasive physiologic interventions associated consist of serial boluses of IV isotonic crystalloid as long as
with EGDT as compared to the appropriate volume resuscitation the patient continues to demonstrate a positive hemodynamic
and targeted therapies that constitute the current usual care of response to fluid loading. Persistent hypotension, despite 30 mL/
shock.11,15,16 Patients in these studies received 2 to 4 L early volume kg of IV fluid, indicates the need to add vasopressors to the resus-
resuscitation and relatively prompt antibiotic administration, citation (see below). If patients require large volumes of crystal-
suggesting that early recognition and initiation of fluid and anti- loid (>4 L), we recommend adding 5- to 10-mL/kg boluses of a
biotic therapy, in conjunction with close monitoring and thought- natural colloid (eg, albumin), rather than additional isotonic crys-
ful care, may be more important than the use of invasive talloid alone, until volume responsiveness is achieved.19 We do not
measurements to attain the specific resuscitation goals suggested recommend use of synthetic colloids, such as hydroxyethyl hetas-
by earlier studies. tarch, which have recently been demonstrated to be associated
with a higher risk of renal failure.20 The infusion of hemoglobin-
Pharmacology based blood substitutes as alternatives to packed red blood cells
(PRBCs) for the resuscitation of hemorrhagic shock has been
Volume Replacement extensively studied and is associated with significant increased
risk of death and myocardial infarction; we recommend against
Most patients with shock can be fully resuscitated with peripheral their use.
venous access established with at least two 18-gauge two catheters.
The goal in volume replacement is slightly elevated left ventricular Blood Products. In the setting of hemorrhage or a critically
end-diastolic volume, which is difficult to measure in the ED. low hemoglobin level (<7g/dL), if criteria for shock persist despite
Historically, CVP has been used to estimate right ventricular crystalloid infusion (see Box 6.2), we recommend transfusion of
filling pressure and is used in some quantitative resuscitation algo- PRBCs (1–2 units in adults or 5–10 mL/kg in children). Fully
rithms. However, CVP measurement does not accurately reflect crossmatched blood is safest and is always preferable unless the
left ventricular end-diastolic volume, and CVP poorly predicts the patient’s need is considered sufficiently urgent to justify the use
hemodynamic response to a fluid challenge. Thus, assessment of of type-specific or even uncrossmatched blood. Use of the latter
fluid responsiveness and fluid resuscitation should not be based is generally confined to patients with hemorrhagic shock with
solely on CVP. A better approach would include the use of the persistent, severe, arterial hypotension and massive or uncon-
clinical response to fluid resuscitation, such as increases in urine trolled hemorrhage. O-negative blood is used in women of child-
output, BP, and decreasing lactate concentrations, alone or in bearing age, and O-positive blood is used in all others (see Chapter
combination with CVP measurements. In patients for whom fluid 111). If patients require more than 2 units of PRBCs for hemor-
resuscitation may be associated with higher risk of harm (eg, rhage, we recommend a balanced resuscitation using PRBCs,
severe systolic heart failure), the use of dynamic variables of fluid fresh-frozen plasma, and platelets in a 1 : 1 : 1 ratio, which is associ-
responsiveness that can be measured from an arterial line (eg, ated with better hemostasis and lower death due to exsanguina-
stroke volume variation, stroke volume index, passive straight leg tion by 24 hours.1
raise) may be beneficial over empirical fluid boluses, but their use The goal hemoglobin target for patients with septic shock in
in the ED has not been studied. the acute resuscitation window, generally defined as the first 6
hours following presentation, remains controversial. A recent
Crystalloids. Standard treatment for hemorrhagic shock his- large randomized controlled trial (RCT) in ICU patients with
torically consisted of rapidly infusing several liters of isotonic septic shock found similar rates of ischemic events, use of life
crystalloid in adults or three successive 20-mL/kg boluses in chil- support, and 90-day mortality among patients transfused at a
dren. Recent studies have endorsed the concept of delayed resus- threshold of 7 g/dL as compared to 9 g/dL.6 Thus, we recommend
citation or hypotensive resuscitation for hemorrhagic shock (see transfusion of PRBCs at a threshold of 7 g/dL in patients with
Chapter 33). No study to date has demonstrated the survival septic shock unless specific contraindications exist or patients
benefit of one type of crystalloid versus another; therefore, the refuse transfusion.
choice of fluids may be less important than scrupulous monitor-
ing for adequate tissue perfusion. Although a single Australian Vasopressors
study has suggested an association between use of chloride-rich
solutions and subsequent renal dysfunction in ICU patients, the The primary goal of vasopressor support is to increase cardiac
study solutions included colloids as well as crystalloids and were output and oxygen delivery to vital organs when crystalloid resus-
not randomized, so any causative inference is not justified.17 citation alone is inadequate. To reduce the potential for limb
Normal saline or lactated Ringer’s solution may be used for damage from extravasation from a peripheral IV injection, vaso-
volume replacement during resuscitation, with no evidence active medications are optimally administered through a central
clearly supporting one over the other. Accordingly, the selection venous catheter, although this is not always feasible in the acute
of isotonic crystalloid solution may be based on institutional, setting. Patients with septic shock who remain hypotensive after
Descargado para Juan Carlos Hoyos Figueroa ([email protected]) en Universidad Ces de ClinicalKey.es por Elsevier en julio 13, 2018.
Para uso personal exclusivamente. No se permiten otros usos sin autorización. Copyright ©2018. Elsevier Inc. Todos los derechos reservados.
74 PART I Fundamental Clinical Concepts | SECTION One Critical Management Principles
Volume
responsive Crystalloid 500–1000-mL bolus
Volume
q15–30 min until unresponsive;
assessment
reassess regularly
Volume
nonresponsive
MAP < 65 mm Hg MAP < 65 mm Hg
Arterial line placement
MAP Norepinephrine (NE) drip @ Vasopressin drip @
5–40 µg/min And NE @ 0.04 U/min
40 µg/min
MAP 65–100
Lactate normal
Fig. 6.2. Flow diagram outlining an example of a formalized resuscitation strategy. This figure illustrates
the sequential targeting of preload, afterload, oxygen supply, and demand matching for sepsis-induced
hypoperfusion. The protocol outlines specific hemodynamic and physiologic parameters that the emer-
gency clinician should seek to attain within the first 6 hours of care. This protocol is focused on resuscita-
tion and should be used in conjunction with standard clinical care for patients with suspected infection,
such as appropriate diagnostic studies, to determine the focus of infection and appropriate antimicrobial
agents to treat the infection. HCT, Hematocrit; ICU, intensive care unit; IJ, internal jugular; INR, interna-
tional normalized ratio; MAP, mean arterial pressure; NS, normal saline; PaCO2, partial pressure of carbon
dioxide, arterial; Sat, peripheral oxygen saturation; SBP, systolic blood pressure; SC, subclavian; ScvO2 ,
central venous oxygen saturation; SIRS, systemic inflammatory response syndrome; WBC, white blood cell
count.
Descargado para Juan Carlos Hoyos Figueroa ([email protected]) en Universidad Ces de ClinicalKey.es por Elsevier en julio 13, 2018.
Para uso personal exclusivamente. No se permiten otros usos sin autorización. Copyright ©2018. Elsevier Inc. Todos los derechos reservados.
CHAPTER 6 Shock 75
a 30-mL/kg fluid bolus generally require vasopressor support. fluoroquinolone and vancomycin, is a rational empirical choice.
Several randomized trials and a meta-analysis have suggested that One such regimen would include piperacillin-tazobactam, 4.5 g
norepinephrine (5–30 µg/min) is associated with improved effi- IV every 6 hours, plus levofloxacin, 750 mg IV every 12 hours,
cacy and lower rates of adverse effects, making norepinephrine the and vancomycin, 30 mg/kg (maximum dose, 2 g) given every
vasopressor of choice for correction of hypotension in septic 12 hours, adjusted as appropriate for trough levels and renal
shock.7 In patients who remain in shock after initial crystalloid failure.
boluses, norepinephrine should be initiated at a rate of 0.05 μg/ Patients with neutropenia and sepsis syndrome are at particu-
kg/min and titrated at 3- to 5-minute intervals until the mean lar risk for progressive sepsis, organ failure, and death. Neutrope-
arterial pressure is greater than 65 mm Hg or the systolic BP is nia can be suspected in patients who have recently undergone
greater than 90 mm Hg. There are no clear data regarding an chemotherapy, and these patients often know that they are neu-
absolute maximum dose, but generally there is little or no addi- tropenic. Antimicrobial administration is particularly urgent for
tional pressor effect once a dose of 30 µg/min has been reached. these patients and should occur rapidly after blood cultures are
Vasopressin can be added as a second vasopressor agent when obtained, in parallel with crystalloid administration. Antibiotic
norepinephrine reaches the maximum dose of 30 µg/min. Vaso- considerations for the neutropenic patient are discussed in
pressin should be administered at a fixed rate of 0.03 to 0.04 units/ Chapter 115. Chemotherapy patients with sepsis represent a
min and should not be titrated. A trial of vasopressin cessation special challenge because the pathophysiology may be compli-
can be attempted once the patient demonstrates improving hemo- cated by anemia, thrombocytopenia, dehydration from vomiting,
dynamics over at least a 6-hour period. Except in cases of a pro- and the effects of adjunctive steroid therapy. Chemotherapy
longed stay in the ED, vasopressors will not be stopped until the patients often have indwelling catheters, which predispose them
patient is in the ICU. Following vasopressor initiation, particularly to more unusual causes of sepsis, including gram-positive bacteria
in patients who require high or rapid upward titration of the and fungi (see Chapters 115 and 187).
vasopressor dose, patients should be reassessed for their respon-
siveness to additional fluid boluses through the use of dynamic Corticosteroids
variables or empirical 500-mL boluses, with careful attention to
the clinical response. Vasopressor support, along with crystalloid There is no evidence for high-dose, short-course corticosteroid
therapy, is continued until the patient can maintain the blood therapy in unselected patients with septic shock. Most current
pressures listed without vasopressor support, which can be tested guidelines recommend that low-dose hydrocortisone be adminis-
at the bedside by weaning the vasopressor agent at a rate of 2 to tered only to patients receiving chronic steroid replacement and
3 µg/min every 5 to 10 minutes. in patients with refractory shock, despite adequate fluid and vaso-
pressor support. Even this is only marginally supported, if at all,
Inotropes by scientific evidence. Corticotropin stimulation testing is no
longer considered of value.
Dobutamine may also be used with norepinephrine to increase
cardiac output and maintain adequate oxygen delivery in cardio- Special Cases
genic and septic shock. In the setting of cardiogenic shock, dobu-
tamine may be indicated by some combination of hypotension, Systemic thrombolytic therapy is indicated in patients with shock
cool extremities, poor urine output, and elevated lactate level. In from pulmonary embolism (see Chapter 78) without contraindi-
the setting of septic shock, if the lactate level does not decrease at cations.21 Specific treatments for shock as a result of poisoning
least 10% and/or the measured ScvO2 does not reach 70%, despite with vasoactive medications and other toxins are discussed in the
fluid resuscitation and vasopressor administration (see earlier), relevant chapters in this text.
dobutamine can be added at a dose of 2 µg/kg/min and titrated
every 5 to 10 minutes, to a maximum of 20 µg/kg/min. Due to Devices and Procedures
stimulation of vasodilating peripheral beta receptors, dobutamine
does have the potential to decrease the BP, so careful attention to Ventilation
a patient’s individual response is necessary. If simultaneous BP
and inotropic support is necessary for septic shock, epinephrine Rapid sequence intubation is the preferred method of airway
alone, 0.2 µg/kg/min starting dose, provides similar outcomes and control in most patients with refractory shock (see Chapter 1).
adverse event rates as a combination of norepinephrine plus Tissue hypoperfusion leads to increasing fatigue of the muscles of
dobutamine. When norepinephrine is the first pressor initiated respiration, and respiratory failure commonly supervenes in
and an inotrope is indicated, we recommend the addition of patients with persistent shock. Intubation prevents aspiration,
dobutamine, with the ability to titrate each agent individually. increases oxygenation, treats acute respiratory failure, provides
However, it is acceptable as an alternative to discontinue the nor- initial treatment for metabolic or hypercarbic acidemia, and pro-
epinephrine and initiate epinephrine infusion to provide vaso- tects the patient who will be sent to an uncontrolled environment
pressor and inotropic support via a single agent. (eg, for testing). Intubation also reduces the work of breathing,
which, in the patient with hypoperfusion, further exacerbates
Antimicrobial Therapy lactic acidemia. Strenuous use of accessory respiratory muscles
can increase oxygen consumption by 50% to 100% and decrease
Treatment of the infection with antimicrobial therapy and, where cerebral blood flow by 50%. More importantly, if the patient has
necessary, surgical drainage (see later, “Source Control”), should increased airway resistance (eg, bronchospasm with anaphylaxis)
be instituted as soon as practical in cases of septic shock.10 Current or a decrease in lung compliance (eg, pulmonary edema, ARDS),
evidence does not support an absolute time requirement for a more negative intrathoracic pressure must be generated to fill
administration but, when septic shock is the working diagnosis the lungs with each inspiration. The greater suction effect is
in the ED, we recommend initiation of appropriate antibiotics also exerted on the left ventricle, impeding its ability to eject
as soon as practical after the diagnosis is made, ideally within 4 and increasing functional afterload. Positive-pressure ventilation
hours of ED presentation. When there is no focus of infection removes this impedance and can improve ventricular function
identified in a patient with presumed septic shock, a semisynthetic and cardiac output up to 30%. The use of etomidate for patients
penicillin with a β-lactamase inhibitor, in combination with a with septic shock is discussed in Chapter 1.
Descargado para Juan Carlos Hoyos Figueroa ([email protected]) en Universidad Ces de ClinicalKey.es por Elsevier en julio 13, 2018.
Para uso personal exclusivamente. No se permiten otros usos sin autorización. Copyright ©2018. Elsevier Inc. Todos los derechos reservados.
76 PART I Fundamental Clinical Concepts | SECTION One Critical Management Principles
KEY POINTS
• Circulatory shock can occur with normal arterial blood pressure, • A combination of a worsening base deficit, increasing lactate level,
and not all patients with arterial hypotension have circulatory and low urine output represents persistent or worsening circulatory
shock. shock.
• A base deficit more negative than −4 mEq/L or a serum lactate • Early initiation of fluid resuscitation, with pressor support as needed,
level greater than 4.0 mmol/L warrants a presumptive diagnosis and appropriate antimicrobial therapy improve the outcomes in
of shock. patients with septic shock.
• Urine output is a reliable index of vital organ perfusion in patients • The use of defined physiologic endpoints to measure systemic
with suspected shock. Normal urine output is 1.0 mL/kg/h. Output perfusion during resuscitation (quantitative resuscitation) improves
less than 0.5 mL/kg/h indicates severe renal hypoperfusion. outcomes for ED patients with shock.
The references for this chapter can be found online by accessing the accompanying Expert Consult website.
Descargado para Juan Carlos Hoyos Figueroa ([email protected]) en Universidad Ces de ClinicalKey.es por Elsevier en julio 13, 2018.
Para uso personal exclusivamente. No se permiten otros usos sin autorización. Copyright ©2018. Elsevier Inc. Todos los derechos reservados.
CHAPTER 6 Shock 76.e1
REFERENCES
1. Holcomb JB, Tilley BC, Baraniuk S, et al: Transfusion of plasma, platelets, and red 11. ProCESS Investigators, Yealy DM, Kellum JA, et al: A randomized trial of protocol-
blood cells in a 1 : 1 : 1 vs a 1 : 1 : 2 ratio and mortality in patients with severe trauma: based care for early septic shock. N Engl J Med 370:1683–1693, 2014.
the PROPPR randomized clinical trial. JAMA 313:471–482, 2015. 12. Jones AE, Shapiro N, Trzeciak S, et al: Lactate clearance vs central venous oxygen
2. Kaukonen KM, Bailey M, Suzuki S, et al: Mortality related to severe sepsis and septic saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 303:739–
shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA 746, 2010.
311:1308–1316, 2014. 13. Puskarich M, Trzeciak S, Shapiro N, et al: Whole Blood lactate kinetics in patients
3. Summers RL, Baker SD, Sterling SA, et al: Characterization of the spectrum of hemo- undergoing quantitative resuscitation for severe sepsis and septic shock. Chest
dynamic profiles in trauma patients with acute neurogenic shock. J Crit Care 28:531– 143:1548–1553, 2013.
535, 2013. 14. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of
4. Odom SR, Howell MD, Silva GS, et al: Lactate clearance as a predictor of mortality severe sepsis and septic shock. N Engl J Med 345:1368–1377, 2001.
in trauma patients. J Trauma Acute Care Surg 74:999–1004, 2013. 15. Peake SL, Delaney A, Bailey M, et al: Goal-directed resuscitation for patients with
5. Hasler RM, Nuesch E, Juni P, et al: Systolic blood pressure below 110 mm Hg is early septic shock. N Engl J Med 371:1496–1506, 2014.
associated with increased mortality in blunt major trauma patients: multicentre 16. Mouncey PR, Osborn TM, Power GS, et al: Trial of early, goal-directed resuscitation
cohort study. Resuscitation 82:1202–1207, 2011. for septic shock. N Engl J Med 372:1301–1311, 2015.
6. Holst LB, Haase N, Wetterslev J, et al: Lower versus higher hemoglobin threshold for 17. Yunos NM, Bellomo R, Hegarty C, et al: Association between a chloride-liberal vs
transfusion in septic shock. N Engl J Med 371:1381–1391, 2014. chloride-restrictive intravenous fluid administration strategy and kidney injury in
7. De Backer D, Aldecoa C, Njimi H, et al: Dopamine versus norepinephrine critically ill adults. JAMA 308:1566–1572, 2012.
in the treatment of septic shock: a meta-analysis. Crit Care Med 40:725–730, 18. Bulger EM, May S, Kerby JD, et al: Out-of-hospital hypertonic resuscitation after
2012. traumatic hypovolemic shock: a randomized, placebo controlled trial. Ann Surg
8. Mutschler M, Nienaber U, Brockamp T, et al: A critical reappraisal of the ATLS clas- 253:431–441, 2011.
sification of hypovolaemic shock: does it really reflect clinical reality? Resuscitation 19. Delaney A, Dan A, McCaffrey J, et al: The role of albumin as a resuscitation fluid for
84:309–313, 2013. patients with sepsis: a systematic review and meta-analysis. Crit Care Med 39:386–
9. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and 391, 2011.
guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus 20. Mutter TC, Ruth CA, Dart AB: Hydroxyethyl starch (HES) versus other fluid thera-
Conference Committee. American College of Chest Physicians/Society of Critical pies: effects on kidney function. Cochrane Database Syst Rev (7):CD007594, 2013.
Care Medicine. 1992. Chest 136:e28, 2009. 21. Konstantinides SV, Torbicki A, Agnelli G, et al, Task Force for the Diagnosis and
10. Dellinger R, Levy M, Rhodes A, et al: Surviving Sepsis Campaign: international guide- Management of Acute Pulmonary Embolism of the European Society of Cardiology
lines for the management of severe sepsis and septic shock 2012. Crit Care Med (ESC): 2014 ESC guidelines on the diagnosis and management of acute pulmonary
41:580–637, 2013. embolism. Eur Heart J 35:3033–3069, 2014.
Descargado para Juan Carlos Hoyos Figueroa ([email protected]) en Universidad Ces de ClinicalKey.es por Elsevier en julio 13, 2018.
Para uso personal exclusivamente. No se permiten otros usos sin autorización. Copyright ©2018. Elsevier Inc. Todos los derechos reservados.